Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that its ...

Aeva, the Aeva logo, Aeva 4D LiDAR ... benefits of the transfer of the Company’s common stock and warrant listings to Nasdaq. Forward-looking statements are predictions, projections and other ...

Aeva ® (NYSE: AEVA), a leader in next-generation sensing and perception systems, today announced that it will transfer the listing of its common stock and its warrants to purchase common stock (NYSE: ...

to the Nasdaq Global Select Market (“Nasdaq”) from the New York Stock Exchange. The Company expects to begin trading as a Nasdaq-listed company on January 28, 2025, with the common stock ...

Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a multi-asset, clinical stage, disease-agnostic life science company delivering an efficient model for compound development, ...

Aeva will transfer the listing of its common stock and its warrants to purchase common stock to the Nasdaq Global Select Market from the NYSE.

The Notice has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market. However, if the Company fails to timely regain compliance with the Listing Rule ...

Group announced that it received a notice on January 15, 2025 from the Listing Qualifications Department of The Nasdaq Stock ...

Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-60. The effective time of ...